New Delhi, Aug 24: In a move aimed at helping patients gain faster access to advanced healthcare technology, the Government of India has proposed amendments to the Medical Devices Rules, 2017, seeking to simplify regulatory requirements, improve transparency and facilitate quicker market access for eligible medical devices.
The Ministry of Health and Family Welfare said the reforms are part of the government’s efforts to promote ease of doing business in the medical-device sector while ensuring that quality, safety and performance standards continue to remain central to the regulatory framework.
For patients and healthcare professionals, the proposed changes could have an important practical impact. Faster and more predictable regulatory processes can help useful medical technologies reach the Indian market sooner, potentially giving doctors and hospitals access to a wider range of tools for diagnosis, treatment and patient care.
One of the key proposals concerns outsourced sterilisation. Manufacturers using a licensed sterilisation facility would no longer need to obtain a separate loan licence, provided the sterilisation facility itself holds a valid licence under the Medical Devices Rules, 2017. The government expects this change to reduce paperwork, compliance requirements, approval timelines and associated costs.
The government has also proposed a uniform fee structure for medical-device testing laboratories through the introduction of a Ninth Schedule under the rules. A standardised fee structure is expected to provide manufacturers and importers with greater clarity and predictability while improving transparency across testing facilities.
Another significant change is the proposed inclusion of the European Union among recognised stringent regulatory jurisdictions for waiver of clinical investigation requirements for eligible medical devices without predicate devices. This could allow certain devices already approved in the EU to gain access to the Indian market more efficiently, subject to applicable regulatory requirements.
The broader objective is to create a regulatory environment where innovation can move faster without compromising patient safety.
As India’s medical-device sector continues to expand, the proposed reforms could support manufacturers, encourage innovation and strengthen the country’s healthcare ecosystem.
Ultimately, the significance of these changes goes beyond regulatory paperwork. For patients, the goal is simple: safe and innovative medical technology should reach those who need it without unnecessary delay.
The proposed reforms therefore represent an effort to build a more efficient, transparent and patient-focused medical-device regulatory system while maintaining the safeguards essential to public health.